Moore Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.16M Buy
72,324
+52,206
+259% +$4.65M 0.13% 129
2025
Q4
$1.59M Buy
+20,118
New +$1.58M 0.02% 404
2024
Q1
Sell
-92,456
Closed -$7.37M 464
2023
Q4
$7.37M Buy
+92,456
New +$6.95M 0.13% 116
2023
Q3
Sell
-37,025
Closed -$2.85M 514
2023
Q2
$2.85M Buy
37,025
+6,588
+22% +$510K 0.05% 222
2023
Q1
$2.29M Buy
+30,437
New +$2.26M 0.05% 236
2016
Q4
Sell
-252,866
Closed -$18.7M 197
2016
Q3
$18.7M Buy
252,866
+247,664
+4,761% +$18.3M 0.64% 34
2016
Q2
$381K Buy
+5,202
New +$370K 0.01% 205
2014
Q4
Sell
-310,000
Closed -$20.2M 324
2014
Q3
$20.2M Buy
+310,000
New +$20.4M 0.47% 50

Other funds holding CL

Moore Capital Management's CL Position: Q1 2026 in Review

Moore Capital Management increased its Colgate-Palmolive (CL) stake by 259% in Q1 2026, buying an estimated $4.65M and bringing the position to 72,324 shares worth $6.16M. The position accounts for 0.13% of the portfolio, ranked #129.

Moore Capital Management first reported a position in CL in Q3 2014 and has held it in 8 quarters since. The position peaked at $20.2M in Q3 2014. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Moore Capital Management held 72,324 shares of Colgate-Palmolive worth $6.16M as of Q1 2026.
  • Moore Capital Management bought 52,206 Colgate-Palmolive shares in Q1 2026, an estimated $4.65M.
  • Colgate-Palmolive made up 0.13% of Moore Capital Management's portfolio in Q1 2026, its #129 holding.
  • Moore Capital Management first reported a position in Colgate-Palmolive in Q3 2014 and has held it in 8 quarters since.
  • Moore Capital Management's Colgate-Palmolive position peaked at $20.2M in Q3 2014.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Moore Capital Management's 13F filing for Q1 2026, filed 15 May 2026.